Arrowstreet Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Arrowstreet Capital’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-31,986	Closed	-$1.98M	–	1302
2022 Q1	$1.98M	Buy	+31,986	New	+$1.96M	﹤0.01%	813
2020 Q3	–	Sell	-63,181	Closed	-$12.5M	–	2394
2020 Q2	$12.5M	Sell	63,181 -13,996	-18%	-$2.9M	0.02%	683
2020 Q1	$15.1M	Sell	77,177 -2,517	-3%	-$542K	0.04%	370
2019 Q4	$16.5M	Buy	+79,694	New	+$14.7M	0.04%	446
2019 Q1	–	Sell	-28,701	Closed	-$2.63M	–	1796
2018 Q4	$2.63M	Sell	28,701 -17,410	-38%	-$1.77M	0.01%	720
2018 Q3	$5.18M	Buy	46,111 +35,086	+318%	+$3.71M	0.01%	504
2018 Q2	$1.02M	Buy	+11,025	New	+$1.07M	﹤0.01%	803
2018 Q1	–	Sell	-38,952	Closed	-$3.65M	–	1201
2017 Q4	$3.65M	Buy	+38,952	New	+$3.68M	0.01%	670
2017 Q3	–	Sell	-2,800	Closed	-$214K	–	1149
2017 Q2	$214K	Buy	+2,800	New	+$236K	﹤0.01%	989

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Arrowstreet Capital's LKFT Position: Q2 2022 in Review

Arrowstreet Capital sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2022, closing a stake of 31,986 shares — an estimated $1.98M sold.

Arrowstreet Capital first reported a position in LKFT in Q2 2017 and held it in 9 quarters. The position peaked at $16.5M in Q4 2019. 82 funds tracked by Wall St. Rank hold LKFT as of Q2 2022.

Arrowstreet Capital reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2022 after selling out during the quarter.
Arrowstreet Capital sold 31,986 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2022, an estimated $1.98M.
Arrowstreet Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and held it in 9 quarters.
Arrowstreet Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $16.5M in Q4 2019.
82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2022.

Based on Arrowstreet Capital's 13F filing for Q2 2022, filed 15 Aug 2022.